Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-103782
Filing Date
2025-04-29
Accepted
2025-04-29 16:08:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d713134ddefa14a.htm DEFA14A 11270
2 GRAPHIC g713134g01g01.jpg GRAPHIC 342913
3 GRAPHIC g713134g02g02.jpg GRAPHIC 186171
  Complete submission text file 0001193125-25-103782.txt   741301
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-42382 | Film No.: 25887448
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)